Funded Tech Companies
Remix Therapeutics
Looking for the VC firms that provided funding to Remix Therapeutics? Alexandria Venture Investments, The Column Group and Atlas Venture joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Remix Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Kendall Sq. Building 200
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Remix Therapeutics is developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways. Powered by our proprietary REMaster technology platform, we can now create medicines with the unique ability to alter the way genes are read from the genome, correcting dysregulation or eliminating the gene message altogether.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/3/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Kevin Bitterman
Chief Operating Officer
Heather Wasserman
Chief Scientific Officer
Peter Smith
Vice President
Dominic Reynolds
Vice President
Jesse Smith
Vice President
Fred Vaillancourt
VP - Bus. Development
Alex Harding
Company Investors
- Alexandria Venture Investments
- The Column Group (Leon Chen)
- Atlas Venture (Kevin Bitterman)
- Foresite Capital (Michael Rome)
- WTT Investment
- Arch Venture Partners (Kristina Burrow)
- Casdin Capital
- Surveyor Capital
- Willett Advisors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs